Abstract:The revolutionary CRISPR/Cas9 gene editing technology holds immense potential for treating genetic diseases and tackling conditions like cancer. However, efficient delivery remains a significant challenge. This is where nanoparticles come into play, emerging as powerful allies in the realm of drug delivery. Nanoparticles can accommodate larger insertion sizes, enabling the incorporation of larger Cas9 enzymes and complex guide RNAs, thus opening up the possibility of editing previously inaccessible genetic regions. Their relatively straightforward and scalable production processes make them cost-effective options for wider applications. Notably, nanoparticles excel in vivo, demonstrating efficient tissue penetration and targeted delivery, which are crucial for maximizing therapeutic impact while minimizing side effects. This review aims to explore the potential of nanoparticle-based delivery systems for CRISPR/Cas9, highlighting their advantages and challenges in gene editing applications. The diverse range of nanoparticles further bolsters their potential. Polymeric nanoparticles, for instance, offer tunable properties for customization and controlled release of the CRISPR cargo. Lipid-based nanoparticles facilitate efficient cellular uptake and endosomal escape, ensuring the CRISPR components reach the target DNA. Even gold nanoparticles, known for their unique biocompatibility and photothermal properties, hold promise in light-activated editing strategies. Non-viral delivery systems, particularly those based on nanoparticles, stand out due to their inherent advantages. Collectively, the evidence paints a promising picture: nanoparticles are not merely passive carriers but active participants in the CRISPR/Cas9 delivery landscape. Their versatility, efficiency, and safety position them as key enablers of a future where gene editing can revolutionize drug development, offering personalized and targeted therapies for a wide range of diseases.

Recent Advances and Challenges in Gene Delivery Mediated by Polyester-Based Nanoparticles

Beyond Lipids: Exploring Advances in Polymeric Gene Delivery in the Lipid Nanoparticles Era

Polymeric Nanocarriers for Non-Viral Gene Delivery

Recent Developments of Polymeric Delivery Systems in Gene Therapeutics

Lipid Nanoparticles: A Novel Gene Delivery Technique for Clinical Application

Polyester-based Nanoparticles for Nucleic Acid Delivery

Recent progress in polymeric gene vectors: Delivery mechanisms, molecular designs, and applications

Cationic Polymeric Nanoformulation: Recent Advances in Material Design for CRISPR/Cas9 Gene Therapy

Polymeric Vehicles for Nucleic Acid Delivery: Enhancing the Therapeutic Efficacy and Cellular Uptake

Nanoparticles in Gene Therapy: Principles, Prospects, and Challenges

Nanoparticle Carriers: A New Era of Precise CRISPR/Cas9 Gene Editing.

Applications and Developments of Gene Therapy Drug Delivery Systems for Genetic Diseases

Current status of polymeric gene delivery systems

Smart Polymeric Nanoparticles for Cancer Gene Delivery

Non-viral Gene Delivery Using Nanoparticles

Nanoparticles for Gene Delivery: A Brief Patent Review

Emerging non-viral vectors for gene delivery

Polymers as Efficient Non-Viral Gene Delivery Vectors: The Role of the Chemical and Physical Architecture of Macromolecules

Microfluidic fabrication of lipid nanoparticles for the delivery of nucleic acids

Viral and Non-Viral Systems to Deliver Gene Therapeutics to Clinical Targets

Nanobiomaterial Vectors for Improving Gene Editing and Gene Therapy